Kronik hepatit B hastalarında serum total magnezyum düzeyi

Amaç: Magnezyum (Mg), karaciğer hasarının gelişiminde etkili olan oksidatif stres ve redoks potansiyellerinde önemli rolü olan bir eser elementtir. Bu çalışmada, hipomagnezemi ile kronik hepatit B hastalarında görülen spesifik olmayan klinik bulguların benzer olması nedeniyle, bu hastalarda serum total Mg düzeyinin irdelenmesi amaçlanmıştır. Yöntem: Bu çalışma Dicle Üniversitesi Tıp Fakültesi ve Midyat Devlet Hastanesi, Enfeksiyon Hastalıkları polikliniklerinde, Nisan 2007-Ağustos 2008 tarihleri arasında takip edilen kronik aktif hepatit B hastaları (n=32), asemptomatik HBs Ag taşıyıcıları (n=37) ve 35 sağlıklı kişiden oluşan kontrol grubuyla yapılmıştır. Bulgular: Çalışmaya alınan üç grup arasında serum albümin ve total Mg düzeyleri açısından istatistiksel olarak anlamlı bir fark bulunamamıştır (p=0,06 ve p=0,22). Sonuç: Kronik aktif hepatit B olgularında ve asemptomatik HBs Ag taşıyıcılarında serum total Mg seviyesi normal referans aralığında tespit edilmiştir.

The evaluation of serum total magnesium level in chronic hepatitis B

Objective: Magnesium (Mg) is a trace element plays an important role in oxidative stress and redox potentials which were effective in the emergence of liver damage. The aim of this study was to evaluate serum total Mg level in chronic hepatitis B patients because the clinical findings of chronic hepatitis B and hypomagnesemia are similar. Methods: This study was carried out in 32 patients with chronic hepatitis B and asymptomatic HBs Ag carrier (n=37) who were followed at the Departments of Infectious Diseases of Dicle University Medical School and Midyat State Hospital, between April 2007 and August 2008, and in 35 healthy controls. Results: We were not detected significant differences between three groups, included to the study, in serum albumin and total magnesium levels (p=0.06 and p=0.22). Conclusion: In conclusion, the serum total magnesium level was determined within normal limits in chronic hepatitis B patients and asymptomatic HBs Ag carrier.

___

  • 1. Bayraktar M. Magnezyum ve magnezyum eksikliği. T Klin Tıp Bilimleri 1990;10:206–10.
  • 2. Özgürtaş T, Kutluay T. Magnezyum metabolizması ve ölçümü. T Klin Tıp Bilimleri 2002;22:530–4.
  • 3. Saha H, Harmoinen A, Karvonen AL, Mustonen J, Pasternack A. Serum ionized versus total magnesium in patients with intestinal or liver disease. Clin Chem Lab Med 1998;36:715-8.
  • 4. Soliman HM, Mercan D, Suzana SML, Melot C, Vincent JL. Development of ionized hypomagnesemia is associated with higher mortality rates. Crit Care Med 2003;31:1082-7.
  • 5. Gürbüz AK. Kronik hepatit B virüs enfeksiyonunda kronikleşme- Kronik B hepatitte klinik ve doğal gidiş. Güncel Gastroenteroloji 2003;7:50–4.
  • 6. Rahelic D, Kujundzic M, Romic Z, Brkic K, Petrovecki M. Serum concentration of zinc, copper, manganese and magnesium in patients with liver cirrhosis. Coll Antropol 2006;30:523-8.
  • 7. Huijgen HJ, Soesan M, Sanders R, Mairuhu WM, Kesecioglu J, Sanders GT. Magnesium levels in critically ill patients. What should we measure? Am J Clin Pathol 2000;114:688-95.
  • 8. Kulpmann WR, Gerlach M. Relationship between ionized and total magnesium in serum. Scand J Clin Lab Invest Suppl 1996;224:251-8.
  • 9. Chacko RT, Chacko A. Serum & muscle magnesium in Indians with cirrhosis of liver. Indian J Med Res. 1997;106:469-74.
  • 10. Rocchi E, Borella P, Borghi A, Paolillo F, Pradelli M, Farina F, Casalgrandi G. Zinc and magnesium in liver cirrhosis. Eur J Clin Invest. 1994;24:149-55.
  • 11. Pasqualetti P, Casale R, Colantonio D, Di Lauro G, Festuccia V, Natali L, Natali G. Serum levels of magnesium in hepatic cirrhosis. Quad Sclavo Diagn. 1987;23:12-7.
  • 12. Göksu N, Ozsoylu S. Hepatic and serum levels of zinc, copper, and magnesium in childhood cirrhosis. J Pediatr Gastroenterol Nutr. 1986;5:459-62.
  • 13. Pramoolsinsap C, Promvanit N, Komindr S, Lerdverasirikul P, Srianujata S. Serum trace metals in chronic viral hepatitis and hepatocellular carcinoma in Thailand. J Gastroenterol. 1994;29:610-5.
  • 14. Kryska A, Juszczyk J, Bereszyńska I, Krajewski P. Trace elements: zinc, copper and magnesium in patients with chronic persisting hepatitis: evaluation of changes during therapy. Pol Tyg Lek. 1990;45:987-9.
  • 15. Zhou X, Cheng F, Nin M. ICP-AES analysis of trace elements in human hair of chronic hepatitis. Guang Pu Xue Yu Guang Pu Fen Xi. 2000;20:361-3.
  • 16. Suzuki K, Oyama R, Hayashi E, Arakawa Y. Liver diseases and essential trace elements. Nippon Rinsho. 1996;54:85-92.
  • 17. Sullivan JF, Blotcky AJ, Jetton MM, Hahn HKJ, Burch RE. Serum levels of selenium, calcium, copper, magnesium, manganase and zinc in various human diseases. J Nutr 1979;109:1432–7.
  • 18. Cohen L. Magnesium and liver cirrhosis: a hypothesis. Magnesium. 1985;4:1-4.
  • 19. Bojanowicz K, Skarbek-Galamon C. Disturbances of fat, carbohydrate, magnesium and protein balance in liver diseases. Acta Hepatogastroenterol (Stuttg). 1977;24:155-161.
  • 20. Pramoolsinsap C, Promvanit N, Kurathong S. Serum trace metal levels in patients with acute hepatitis B. Southeast Asian J Trop Med Public Health. 1996; 27.476–80.